CureLauncher is crowdfunding new cancer treatments to accelerate development.
The fiscal cliff is calling for funding to the National Institutes of Health to be cut by $2.5 billion and eliminate 2,100 research grants, including 300 through the National Cancer Institute, said the Biotechnology Industry Organization.
Many life-saving cancer treatments will never reach people who need them because researchers won’t obtain the funding needed for testing. Now, cureLauncher.com gives everyone a place to see new treatments in development and connect with the dedicated scientists who are saving lives.
“CureLauncher is the only crowdfunding platform dedicated to NIH-caliber drug and medical device research”, said Founder and President, Stephen Goldner, JD, RAC. “CureLauncher.com provides funding for medical treatments and provides easy access to clinical trials for anyone needing lifesaving medical treatments. There are 500 enrolling breast cancer medical research trials on cureLauncher right now”.
The featured project is a new metastatic breast cancer treatment from esteemed cancer researcher Dr. Lee Roy Morgan, CEO of DEKK-TEC. Each person who contributes $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan’s reply.
“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving patients’ lives”.
Instead of waiting 2 years for NIH grant money, researchers now have a way of connecting with people who care about their research to generate support. Anyone who’s been affected by cancer can see Dr. Morgan’s new treatment and contribute to its development. Everyone who contributes receives a personal thank you and other items to recognize their support. They can also schedule a phone call to speak directly with Dr. Morgan.
CureLauncher is truly a disruptive innovation. “It is a transformative change in American medical funding and enables researchers to continue developing lifesaving new treatments, said Vice President, David Fuehrer. “As a two-time cancer survivor, I know how alone this disease can make people feel. Supporting each other and new treatments is the only way to win the fight against cancer”.
Visit http://www.curelauncher.com to learn more and support this new breast cancer treatment.
